Medi Assist Healthcare Intrinsic Value

Medi Assist Healthcare intrinsic value. Medi Assist Healthcare (MEDIASSIST) median intrinsic value is ₹244.31 from 10 valuation models (range ₹84–₹433), vs current price ₹279.80 — -12.7% downside (Trading Above Median Value), margin of safety -14.5%. Analyse MEDIASSIST shareholding pattern to track promoter, FII and institutional holdings.

Market Price (CMP)
₹279.80
Primary Intrinsic Value
₹138.24
Market Cap
₹1035 Cr
-12.7% Downside
Median Value
₹244.31
Value Range
₹84 - ₹433
Assessment
Trading Above Median Value
Safety Margin
-14.5%

MEDIASSIST Valuation Methods Summary — DCF, Graham Number & P/E

Medi Assist Healthcare intrinsic value across 10 models vs current price ₹279.80 — upside/downside and value range per method. Browse MEDIASSIST annual financials for revenue, profit, balance sheet and cash flow data.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹138.24 ₹110.59 - ₹165.89 -50.6% EPS: ₹11.52, Sector P/E: 12x
Book Value Method asset ₹184.22 ₹165.80 - ₹202.64 -34.2% Book Value/Share: ₹230.27, P/B: 0.8x
Revenue Multiple Method revenue ₹264.86 ₹238.37 - ₹291.35 -5.3% Revenue/Share: ₹264.86, P/S: 1.0x
EBITDA Multiple Method earnings ₹286.49 ₹257.84 - ₹315.14 +2.4% EBITDA: ₹212.00Cr, EV/EBITDA: 5x
Simple DCF (5Y) dcf ₹433.20 ₹346.56 - ₹519.84 +54.8% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹83.94 ₹75.55 - ₹92.33 -70.0% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹94.92 ₹85.43 - ₹104.41 -66.1% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹285.41 ₹256.87 - ₹313.95 +2.0% ROE: 10.3%, P/E Multiple: 12x
Graham Defensive Method conservative ₹244.31 ₹219.88 - ₹268.74 -12.7% EPS: ₹11.52, BVPS: ₹230.27
Dividend Yield Method dividend ₹83.94 ₹75.55 - ₹92.33 -70.0% DPS: ₹2.00, Target Yield: 4.0%
Method Types: Earnings Asset DCF Growth Dividend Conservative

MEDIASSIST Intrinsic Value vs Market Price — All Valuation Models

Medi Assist Healthcare fair value range ₹84–₹433 vs current market price ₹279.80 across 10 valuation models. For current market price and key ratios, visit Medi Assist Healthcare screener.

MEDIASSIST Intrinsic Value Analysis — Undervalued or Overvalued?

Medi Assist Healthcare median intrinsic value ₹244.31, current price ₹279.80 — Trading Above Median Value by 12.7%, margin of safety -14.5%.

What is the intrinsic value of MEDIASSIST?

Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Medi Assist Healthcare (MEDIASSIST) is ₹244.31 (median value). With the current market price of ₹279.80, this represents a -12.7% variance from our estimated fair value.

The valuation range spans from ₹83.94 to ₹433.20, indicating ₹83.94 - ₹433.20.

Is MEDIASSIST undervalued or overvalued?

Based on our multi-method analysis, Medi Assist Healthcare (MEDIASSIST) appears to be trading above median value by approximately 12.7%.

MEDIASSIST Financial Health — Key Ratios vs Industry Benchmarks

Medi Assist Healthcare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Return on Equity 10.3% Industry Standard: 15%+ Above 10% Measures shareholder return efficiency
Operating Margin 20.0% Industry Standard: 20%+ Above 20% Indicates operational efficiency level
Asset Turnover Ratio 0.71x Industry Standard: 1.0x+ Above 0.5x Measures asset utilization efficiency

MEDIASSIST Cash Flow Quality — Operating & Free Cash Flow

Medi Assist Healthcare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹118 Cr ₹39 Cr Positive Free Cash Flow 7/10
March 2025 ₹138 Cr ₹29 Cr Positive Free Cash Flow 7/10
March 2024 ₹66 Cr ₹39 Cr Positive Free Cash Flow 8/10
March 2023 ₹81 Cr ₹76 Cr Positive Free Cash Flow 8/10
March 2022 ₹64 Cr ₹23 Cr Positive Free Cash Flow 7/10